The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.

모더나의 암 백신은 Keytruda 대비 우위보다 장기 재발 방지 여부가 핵심이라는 분석으로, 단기 주가 방향성은 중립적입니다.

AI CATALYST SCORE50 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

MRNA Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-10-25 12:05:03	MRNA	45	Mid	View Report →
2026-10-24 12:28:05	MRNA	65	Mid	View Report →
2026-10-23 19:02:09	MRNA	50	Mid	View Report →

RELATED REPORTS

Diagnosed At	Ticker	AI Score	Tier
2026-10-25 16:22:07	AZN	82	Mid	View Report →
2026-10-25 11:15:41	GMAB	50	Mid	View Report →
2026-10-24 19:59:13	AMGN	62	Mid	View Report →
2026-10-24 18:08:27	ZYME	64	Mid	View Report →
2026-10-24 14:39:24	AMGN	90	Mid	View Report →
2026-10-24 14:16:22	LLY	65	Mid	View Report →
2026-10-24 05:57:34	ALLO	30	Row	View Report →
2026-10-24 01:58:48	VRTX	60	Mid	View Report →
2026-10-23 20:03:59	BMY	45	Mid	View Report →
2026-10-23 19:12:59	IOVA	62	Mid	View Report →
2026-10-23 14:52:37	ALNY	68	Mid	View Report →
2026-10-23 06:33:51	ZLAB	40	Row	View Report →
2026-10-23 02:12:35	UTHR	42	Row	View Report →
2026-10-23 01:00:24	RAPP	55	Mid	View Report →
2026-10-22 13:42:28	LNTH	45	Mid	View Report →
2026-10-22 03:44:42	RCUS	45	Mid	View Report →
2026-10-22 02:29:00	QGEN	35	Row	View Report →
2026-10-21 23:40:16	AZN	75	S-Class	View Report →
2026-10-21 22:28:36	ELVN	30	Row	View Report →
2026-10-21 22:17:06	RCUS	45	Mid	View Report →
2026-10-21 21:07:23	UTHR	40	Row	View Report →
2026-10-21 20:06:40	QGEN	78	Mid	View Report →
2026-10-21 16:24:01	UNCY	50	Mid	View Report →
2026-10-21 06:40:51	IRON	45	Mid	View Report →
2026-10-21 02:08:07	NTRA	35	Row	View Report →
2026-10-20 22:03:40	NVO	85	Mid	View Report →
2026-10-20 21:24:12	INO	68	Mid	View Report →
2026-10-20 19:52:37	ANAB	45	Mid	View Report →
2026-10-20 18:55:24	SLN	65	Mid	View Report →
2026-10-20 16:54:23	QGEN	82	S-Class	View Report →